コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 erwent magnetic resonance imaging to exclude arrhythmogenic right ventricular dysplasia.
2 orphic ventricular tachycardia and a form of arrhythmogenic right ventricular dysplasia.
3 rces for arrhythmias, even in the absence of arrhythmogenic right ventricular dysplasia.
4 detailed echocardiography, in patients with arrhythmogenic right ventricular dysplasia.
5 r therapy in the management of patients with arrhythmogenic right-ventricular dysplasia.
6 gnetic resonance imaging in the diagnosis of arrhythmogenic right-ventricular dysplasia.
8 yopathy, left ventricular noncompaction, and arrhythmogenic right ventricular dysplasia; and delineat
9 lymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia (ARVD) affect
10 etic resonance imaging (MRI) examinations of arrhythmogenic right ventricular dysplasia (ARVD) and to
11 The loci of several genes responsible for arrhythmogenic right ventricular dysplasia (ARVD) have b
22 r structural abnormalities characteristic of arrhythmogenic right ventricular dysplasia, but right ve
23 earch has described the arrhythmic course of arrhythmogenic right ventricular dysplasia/cardiomyopath
24 entricular contractions (PVCs) are common in arrhythmogenic right ventricular dysplasia/cardiomyopath
25 Arrhythmogenic right ventricular dysplasia/cardiomyopath
26 We hypothesized that VT in arrhythmogenic right ventricular dysplasia/cardiomyopath
27 entricular arrhythmias in patients harboring arrhythmogenic right ventricular dysplasia/cardiomyopath
28 ermine how exercise influences penetrance of arrhythmogenic right ventricular dysplasia/cardiomyopath
29 hythmic risk stratification in patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
30 The study population included 16 consecutive arrhythmogenic right ventricular dysplasia/cardiomyopath
31 acycline cardiomyopathy, cardiac tumors, and arrhythmogenic right ventricular dysplasia/cardiomyopath
32 r tachycardia (VT) ablation in patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
33 Arrhythmogenic right ventricular dysplasia/cardiomyopath
34 Arrhythmogenic right ventricular dysplasia/cardiomyopath
35 ricular tachycardia (VT) among patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
36 icular arrhythmias distinguish patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
37 defibrillator (ICD) therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopath
38 lying right ventricular (RV) dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopath
39 ent in individuals predisposed to developing arrhythmogenic right ventricular dysplasia/cardiomyopath
40 ion (RFA) of ventricular tachycardia (VT) in arrhythmogenic right ventricular dysplasia/cardiomyopath
41 s have been identified as the major cause of arrhythmogenic right ventricular dysplasia/cardiomyopath
42 Arrhythmogenic right ventricular dysplasia/cardiomyopath
43 Arrhythmogenic right ventricular dysplasia/cardiomyopath
44 Arrhythmogenic right ventricular dysplasia/cardiomyopath
45 Arrhythmogenic right ventricular dysplasia/cardiomyopath
46 Arrhythmogenic right ventricular dysplasia/cardiomyopath
47 M and they were diagnostic or suggestive for arrhythmogenic right ventricular dysplasia/cardiomyopath
48 utations among family members of people with arrhythmogenic right ventricular dysplasia/cardiomyopath
49 Arrhythmogenic right ventricular dysplasia/cardiomyopath
50 RI) for noninvasive detection of fibrosis in Arrhythmogenic right ventricular dysplasia/cardiomyopath
51 ow overlap in the clinical presentation with arrhythmogenic right ventricular dysplasia/cardiomyopath
52 Arrhythmogenic right ventricular dysplasia/cardiomyopath
53 m of this study was to assess the outcome of arrhythmogenic right ventricular dysplasia/cardiomyopath
54 Arrhythmogenic right ventricular dysplasia/cardiomyopath
55 ovirus (CMV), enterovirus and parvovirus, in arrhythmogenic right ventricular dysplasia/cardiomyopath
56 diomyopathy (ie, restrictive cardiomyopathy, arrhythmogenic right ventricular dysplasia/cardiomyopath
57 lete penetrance and variable expressivity of arrhythmogenic right ventricular dysplasia/cardiomyopath
58 can in turn facilitate ablation of the VT in arrhythmogenic right ventricular dysplasia/cardiomyopath
59 imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopath
60 Arrhythmogenic right ventricular dysplasia/cardiomyopath
63 d the pathogenesis of both Uhl's anomaly and arrhythmogenic right ventricular dysplasia; in each apop
66 nt new breakthroughs in the genetic basis of arrhythmogenic right-ventricular dysplasia; it now appea
68 pertrophic cardiomyopathy, and patients with arrhythmogenic right ventricular dysplasia or channelopa
69 This may explain why arrhythmogenic right-ventricular dysplasia preferentiall
70 Ten patients with the clinical diagnosis of arrhythmogenic right ventricular dysplasia were included
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。